A Multi-Center, 12-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Safety and Tolerability of the Neutrophil Elastase Inhibitor PHP-303 in Adults with Alpha-1 Antitrypsin Deficiency (AATD)
100 项与 Ph Pharma, Inc. 相关的临床结果
0 项与 Ph Pharma, Inc. 相关的专利(医药)
100 项与 Ph Pharma, Inc. 相关的药物交易
100 项与 Ph Pharma, Inc. 相关的转化医学